Category Medicine and Healthcare
Press Release
Aptevo Therapeutics Provides Program Update for Bispecific APVO711, a PD-L1 X CD40 that Combines a Checkpoint Inhibitor and Immune Activation
As lead candidate mipletamig continues to outperform efficacy and safety benchmarks in AML trials, APVO711 exemplifies emerging innovation from Aptevo's proprietary ADAPTIR® platform In preclinical studies, APVO711 demonstrates dual anti-cancer functionality with broad solid tumor potential and developability Read More
Press Release
MIRA Pharmaceuticals Announces Board Approval of SKNY Acquisition Reflecting $60+ Million in Combined Enterprise Value Based on Independent Review
With valuations confirmed by the board, MIRA advances strategic acquisition targeting obesity and nicotine dependence, which includes a $5 million contribution in cash or assets from SKNY to be transferred at closing. Read More
Press Release
Black Book Research Celebrates Women's Health Month With Complimentary Release of Comprehensive 2025 Industry Report on Women's Health IT Innovations
New IT Sector Report Evaluates 300+ Vendors Across 40 Categories, Revealing 2025's Top-Rated Solutions in Women's Health Technology Read More
Press Release
Interactive Strength Inc. (Nasdaq:TRNR) Provides Shareholder Update on Sportstech’s Strong April 2025 and LTM Performance
Sportstech Announced Strong Results, with April 2025 revenue growth at 36% YOY Current FX rates indicate that the LTM figures would be approximately $54M in Revenue and $5M in EBITDA through April 2025 Strong Business Momentum, Revenue and Positive EBITDA Underscore Target's Operational Strength and Logic of Acquisition in advance of Closing Read More
Press Release
DEA Marijuana SCAM Violates the Public Interest, MMJ To File Suit Against DEA Yet Again
DEA's Diversion Control Division leadership implicated in the obstruction of MMJ 's DEA registration and delays in cannabis-based pharmaceutical research are Thomas W. Prevoznik, Matthew Strait and DEA Administrative Law Judges (ALJs) all who under the agency's control, raising serious concerns about due process, impartiality, and accountability. Read More
Press Release
eXoZymes Launches Subsidiary, NCTx, to Unlock a Promising Compound for Gut and Liver Health
N-trans-caffeoyltyramine (NCT) is a natural product compound attracting considerable interest from researchers and drug developers for its potential role in healthy liver fat metabolism, gut barrier function, and mitochondrial activity. eXoZymes used its AI-driven development platform to progress from idea to purpose-built subsidiary in less than 3 months and at a fraction of normal SynBio R&D cost. NCTx is scaling up an exozyme biosolution to overcome a longstanding bottleneck in sourcing the NCT compound from nature, where it occurs only in trace amounts. Interesting pre-clinical data point towards Non-Alcoholic Fatty Liver Disease (NAFLD) that affects more than 30% of the global population. Only NCTx can make both the natural product NCT, and a range of very interesting new-to-nature analog versions, expanding the pharma potential. NCT is the first of more "powered by eXoZymes" natural product nutraceuticals, that also have the potential to become pharmaceuticals. Read More
Press Release
Protagonist Reports First Quarter 2025 Financial Results and Provides Corporate Update
Positive top line results from rusfertide Phase 3 VERIFY trial in polycythemia vera (PV) announced; full data selected for oral presentation during plenary session at ASCO on June 1st Conference call to be held June 2nd at 8AM EDT to discuss rusfertide data presented at ASCO Full dataset from Phase 3 ICONIC-LEAD trial with icotrokinra in patients with moderate-to-severe plaque psoriasis (PsO) presented at the 2025 AAD Meeting in March; data from adolescent subset presented at World Congress of Pediatric Dermatology in April Positive top line results from icotrokinra Phase 2b ANTHEM trial in moderately to severely active ulcerative colitis (UC) announced in March, data to be presented at medical conference later in 2025 Cash, cash equivalents and marketable securities of $697.9 million as of March 31, 2025, anticipated to provide cash runway through at least end of 2028 Read More
Press Release
Electronic Caregiver Launches First-Ever AI-Powered Virtual Care Ecosystem Featuring Interactive Avatar, Now Available via Athenahealth’s EHR Network
Addison Care delivers the industry's most comprehensive AI-enabled chronic care platform - offering vitals monitoring, automated wellness checks, caregiver support, and integrated TeleCare services - now accessible to thousands of clinics through Athenahealth's nationwide EHR ecosystem. Read More
Press Release
Nerva Completes Mahana Therapeutics Acquisition to Expand Access to Digital Therapies for IBS
Nerva, the world's leading digital therapeutic for Irritable Bowel Syndrome (IBS), announced today that it has acquired key assets of Mahana Therapeutics, a pioneer in digital therapies for chronic conditions, including IBS. Read More
Press Release
MIRA Pharmaceuticals Reports No Brain Toxicity in FDA-Required Study of Ketamir-2, Confirming Absence of Ketamine-Linked Neurotoxicity
Preclinical data supports the advancement of oral Ketamir-2 as a safe, next-generation alternative to ketamine, with ongoing momentum in Phase I clinical trial enrollment Read More
Press Release
Northway Biotech Launches Full-Service Viral Clearance Studies, Delivering Results Faster Than Industry Standards
With six newly established, identical BSL-2 laboratories now operational, biologics CDMO Northway Biotech can conduct VCS programs for up to six clients simultaneously, significantly alleviating current market bottlenecks Read More
Press Release
DEA Diversion in Cannabis Chaos: MMJ Urges Terrance Cole, President Trump DEA Nominee to Dismantle Biden Era Cannabis Obstructors
Message to President Trump's Appointee: Terrance Cole Must Act on Cannabis Scientific Reform. "Mr. Cole has a historic opportunity to lead with integrity, science, and constitutional fidelity," said Boise. "He must put an end to this unlawful administrative hearing, root out DEA institutional marijuana bias, and restore lawful science-based regulatory practices." Read More
Press Release
Compassion Center Launches Social Media Giveaway for Psychedelic Science 2025 Conference
Compassion Center announces a dynamic giveaway contest, offering two exclusive tickets to Psychedelic Science 2025. Participants can win by maximizing social media shares or submitting compelling personal statements. Contestants must engage with Compassion Center's social channels, with winners announced on May 25, ahead of the prestigious June conference. Read More
Press Release
ZetrOZ Systems Announces Partnership with Arthritis Foundation to Transform Arthritis Patient Education
The developer of sustained acoustic medicine technology and the sam® wearable ultrasound device and number one resource for arthritis information will support the Foundation's efforts to provide resources and education to patients, families and caregivers. Read More
Press Release
Venture Medical Announces Strategic Partnership With Plasmacure to Bring Proven Cold Plasma Therapy System for Wound Healing to the U.S. Market
This agreement will introduce a new technology that has already demonstrated strong results in promoting wound healing to the United States. Read More
Press Release
PharmaNest Launches FibroMAP, the First Single-Fiber Phenotypic Tool for the Study of Fibrosis Across Biological Models and Indications
FibroMAP combines the power of high-resolution, single-fiber, and spatially resolved datasets generated by PharmaNest's digital pathology and image analysis platform (FibroNest) with advanced clustering techniques such as Uniform Manifold Approximation and Projection (UMAP) to interpret complex, high-dimensional data. FibroMAP is poised to revolutionize the study of fibrosis histology in the same way that single-cell analysis transformed biology. Read More
Press Release
